Program Overview
The joint providership of Annenberg Center for Health Sciences at Eisenhower, Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) presents The Cholestasis Collaborative: Advancing Diagnosis and Management of Cholestatic Liver Disease. This educational activity will provide healthcare professionals with comprehensive insights into the diagnosis and management of progressive familial intrahepatic cholestasis (PFIC), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
Target Audience
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, nurse practitioners, nurses, and physician assistants/associates involved in the management of patients with progressive familial intrahepatic cholestasis (PFIC), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
Educational Objectives
Upon completion of this activity, participants should be able to:
-
Recognize the clinical consequences and progression of chronic cholestatic diseases, with emphasis on pruritus, fatigue, and progressive liver damage in progressive familial intrahepatic cholestasis (PFIC), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
-
Identify current diagnostic challenges and apply diagnostic algorithms for the early and precise differentiation of progressive familial intrahepatic cholestasis (PFIC), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC).
-
Evaluate the efficacy and safety profiles of novel and emerging therapeutic strategies for managing symptoms (e.g., pruritus, fatigue) and addressing specific disease progression in PFIC, PBC, and PSC.
-
Develop comprehensive, multidisciplinary and interprofessional management strategies for cases of PFIC, PBC, and PSC.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower, Chronic Liver Disease Foundation, and Gastroenterology & Hepatology Advanced Practice Providers. Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Associate Credit
The Annenberg Center for Health Sciences at Eisenhower has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Physician Credit
The Annenberg Center for Health Sciences at Eisenhower designates this meeting series for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Credit
The Annenberg Center for Health Sciences at Eisenhower designates this Meeting Series for a maximum of 2.0 ANCC contact hours, which will include pharmacology hours.
Disclosure of Relevant Financial Relationships
All individuals in control of the content of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience all relevant financial relationships related to the content of the presentation or enduring material. Full disclosure of all relevant financial relationships will be made in writing to the audience prior to the activity. All other staff at the Annenberg Center for Health Sciences at Eisenhower, Chronic Liver Disease Foundation, and Gastroenterology & Hepatology Advanced Practice Providers, who impacted the content of this activity, have no relevant financial relationships to disclose.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to mitigating all relevant financial relationships that could arise as a result of individuals who control activity content and who have relevant financial relationships with ACCME-defined ineligible companies. The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those individuals with relevant financial relationships that can be reconciled with the goals and educational integrity of the CE activity.
All relevant financial relationships disclosed during this activity have been mitigated.
Disclaimer
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Annenberg Center for Health Sciences at Eisenhower Privacy Policy
Policy: Annenberg Center for Health Sciences respects your privacy. We do not share information you give us or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at https://annenberg.net/pages/privacyPolicy.php.
Fee information: There is no fee for this educational activity.
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower, Chronic Liver Disease Foundation, and Gastroenterology & Hepatology Advanced Practice Providers.
Supported by educational grants from Ipsen Biopharmaceuticals, Inc. and Mirum Pharmaceuticals, Inc.